Evaluating the AltaValve as a novel method for transcatheter mitral valve replacement

Area of Science:

• Cardiology
• Interventional Cardiology
• Biomedical Engineering

Background:

• Mitral regurgitation (MR) is a common heart valve disease with poor prognosis if untreated.
• Severe MR often necessitates intervention, but many patients are high-risk surgical candidates.
• Transcatheter mitral valve replacement (TMVR) is an emerging less invasive alternative.

Purpose of the Study:

• To evaluate the safety and feasibility of the AltaValve system for transcatheter mitral valve replacement.
• To address limitations of current TMVR techniques, including anatomical challenges and left ventricular outflow tract (LVOT) interaction.
• To assess the potential of a supra-annular TMVR device for a broader patient population.

Main Methods:

• The AltaValve system features a supra-annular design for fixation in the left atrium.
• The device avoids anchoring mechanisms that could interfere with the left ventricle (LV).
• Initial safety and feasibility data were collected from a patient cohort.

Main Results:

• The AltaValve system's supra-annular design aims to prevent LVOT obstruction and LV damage.
• The design seeks to reduce the risk of prosthesis embolization.
• Initial data indicate encouraging safety and feasibility of the AltaValve system.

Conclusions:

• The AltaValve system presents a novel approach to TMVR, potentially overcoming existing limitations.
• Its supra-annular design may offer advantages in complex mitral valve anatomy and LVOT interaction.
• Further investigation with larger patient cohorts and longer follow-up is required to confirm safety and efficacy.